Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP compliant guideline study, available as unpublished report, no restrictions, fully adequate for assessment.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2008
Report date:
2008

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Qualifier:
according to guideline
Guideline:
EU Method B.3 (Acute Toxicity (Dermal))
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.1200 (Acute Dermal Toxicity)
GLP compliance:
yes
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorooctane
EC Number:
700-684-7
Cas Number:
80793-17-5
Molecular formula:
C8H5F13
IUPAC Name:
1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorooctane
Details on test material:
- Name of test material (as cited in study report): 1,1,1,2,2,3,3,4,4,5,5,6,6-Tridecafluorooctane
- Physical state: clear colourless liquid
- Batch number: 070412
- Purity: 99.9%
- Storage condition of test material: at room temperature in the dark
- Stability under storage conditions: stable

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Deutschland, Sulzfeld, Germany
- Age at study initiation: 8 weeks
- Weight at study initiation: 244-259 g (males); 166-188 g (females)
- Fasting period before study: no
- Housing: individually housed in labeled Macrolon cages (Mill type, height 18 cm) containing sterilized sawdust as bedding material (Litalabo, S.P.P.S., Argenteuil, France) and paper as cage-enrichment (Enviro-dri, Lillico & Son (Wonham Mill Ltd), Surrey, United Kingdom)
- Diet: pelleted rodent diet (SM R/M-Z from SSNIFF® Spezialdiäten, GbmH, Soest, Germany), ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19.5-21.6
- Humidity (%): 31-58
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12 / 12

Administration / exposure

Type of coverage:
occlusive
Vehicle:
unchanged (no vehicle)
Details on dermal exposure:
TEST SITE
- Area of exposure: 25 cm2 (males); 18 cm2 (females)
- % coverage: 10
- Type of wrap if used: Surgical gauze patch (Surgy 1D), covered with aluminum foil and Coban elastic bandange. Micropore tape was additionally used for fixation of the bandages in females only.

REMOVAL OF TEST SUBSTANCE
- Washing (if done): yes, using tap water
- Time after start of exposure: 24 hours

TEST MATERIAL
- Amount(s) applied: 1.287 mL/kg bw
- Constant volume or concentration used: yes
Duration of exposure:
24 hours
Doses:
2000 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations at periodic intervals on the day of dosing (day 1), and once daily thereafter until day 15; weighing on day 1, 8, 15 and at death
- Necropsy of survivors performed: yes

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
One male was found dead on day 2. No further mortality occurred.
Clinical signs:
other: The males showed hunched posture, ptosis, chromodacryorrhea and/or flat posture on days 1 and 2. Two females showed chromodacryorrhea on days 1 and/or 2.
Gross pathology:
No abnormalities were found at macroscopic post mortem examination of the animals.
Other findings:
Scabs were seen in the treated skin-area of one male during the study period.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
The dermal LD50 of AC-6000 in Wistar rats is >2000 mg/kg body weight.
Executive summary:

The acute dermal toxicity study was conducted in accordance with OECD 402 (Acute Dermal Toxicity), EU Method B.3 (Acute Toxicity (Dermal)), and EPA OPPTS 870.1200 (Acute Dermal Toxicity) guidelines. AC-6000 was applied dermally to male and female Wistar rats. The test substance was held in place for 24 hrs to an area approximately 10% of the total body surface, after which dressings were removed and residual test substance washed off with tap water. One male was found dead on Day 2. No further mortality occurred. On Days 1 and/or 2 males showed hunched posture, ptosis, chromodacyorrhea and/or flat posture, and two females showed chromodacryorrhea. One male had scabs on the treated skin-area. Changes in body weight were within the range expected for rats used in this type of study, and were not considered indicative of toxicity. There were no macroscopic abnormalities found at necropsy. Therefore, the dermal LD50 of AC-6000 in Wistar rats is >2000 mg/kg body weight.